文献速递血栓与止血MDS 与骨髓增殖性肿瘤

真性红细胞增多症与原发性血小板增多症的血栓栓塞事件、大出血及死亡率:一项匹配的全国人群研究

Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera-A matched nationwide population-based study.
PubMed 文献 · Br J Haematol · 2024-02-13

利用瑞典多个医疗登记数据库,比较3141例原发性血小板增多症(ET)和2604例真性红细胞增多症(PV)患者与匹配对照者的动脉和静脉事件、大出血、全因卒中及全因死亡率。ET和PV患者每100治疗年的静脉血栓栓塞、大出血和全因死亡率均显著高于对照,PV患者动脉事件和全因卒中率也显著升高。

要点

  • ET患者静脉血栓栓塞、大出血和全因死亡率每100治疗年分别为0.63、0.79和3.70,均显著高于对照。
  • PV患者静脉血栓栓塞、大出血和全因死亡率每100治疗年分别为0.94、1.20和4.80,均显著高于对照。
  • PV患者动脉事件和全因卒中率显著高于对照,且所有年龄组动脉和静脉事件率均显著升高。

核心结论

  • 本研究证实PV和ET是真正以血栓栓塞并发症和出血为特征的疾病。

研究设计与样本

  • 利用瑞典多个医疗登记数据库开展的匹配全国人群研究。
  • 纳入3141例ET患者和2604例PV患者,每例患者随机选取5名匹配对照。

主要发现

  • ET组和PV组分别观察到327和405例动脉或静脉事件。
  • 与相应对照相比,ET患者每100治疗年的静脉血栓栓塞、大出血和全因死亡率分别为0.63、0.79和3.70,均显著增高。
  • 与相应对照相比,PV患者每100治疗年的静脉血栓栓塞、大出血和全因死亡率分别为0.94、1.20和4.80,均显著增高。
  • PV患者动脉事件和全因卒中率也显著高于对照。
  • 按年龄分组后,PV患者所有年龄组的动脉和静脉事件率均显著升高;50岁以上各年龄组ET和PV患者的全因死亡率均显著升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thromboembolic events and bleeding are known complications in essential thrombocythaemia (ET) and polycythaemia vera (PV). Using multiple Swedish health care registers, we assessed the rate of arterial and venous events, major bleeding, all-cause stroke and all-cause mortality in ET and PV compared to matched controls. For each patient with ET (n = 3141) and PV (n = 2604), five matched controls were randomly selected. In total, 327 and 405 arterial or venous events were seen in the group of ET and PV patients respectively. Compared to corresponding controls, the rate of venous thromboembolism, major bleeding and all-cause mortality per 100 treatment years was significantly increased among both ET (0.63, 0.79 and 3.70) and PV patients (0.94, 1.20 and 4.80). The PV patients also displayed a significantly higher rate of arterial events and all-cause stroke compared to controls. When dividing the cohort into age groups, we found a significantly higher rate of arterial and venous events in all age groups of PV patients, and the rate of all-cause mortality was significantly higher in both ET and PV patients in all ages above the age of 50. This study confirms that PV and ET are diseases truly marked by thromboembolic complications and bleeding.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Enblom-Larsson A, Renlund H, Andréasson B, et al. Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera-A matched nationwide population-based study. Br J Haematol. 2024. PMID: 38351734. doi:10.1111/bjh.19337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。